{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:15:56Z","timestamp":1788362156863,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tracli.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:48:49Z","timestamp":1779925729000},"page":"165-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis"],"prefix":"10.1016","volume":"33","author":[{"given":"Suhasini","family":"Sil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem Chandra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvi","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanchi","family":"Khiamniungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Naseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Coshic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2026.05.006_bib0080","doi-asserted-by":"crossref","first-page":"e0265951","DOI":"10.1371\/journal.pone.0265951","article-title":"The clinical demand and supply of blood in India: a national level estimation study","volume":"17","author":"Mammen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tracli.2026.05.006_bib0085","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1537-2995.2009.02443.x","article-title":"Moderate and severe adverse events associated with apheresis donations: incidences and risk factors","volume":"50","author":"Yuan","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2026.05.006_bib0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jca.21565","article-title":"A liquid calcium\u00a0+\u00a0vitamin D3\u00a0supplement is effective prophylaxis against hypocalcemic toxicity during apheresis platelet donation","volume":"33","author":"Weinstein","year":"2017","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2026.05.006_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0973-6247.106730","article-title":"Adverse events associated with apheresis procedures: incidence and relative frequency","volume":"7","author":"Philip","year":"2013","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2026.05.006_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jca.21753","article-title":"Delayed adverse events in male plateletpheresis donors: initial insights on donor safety","volume":"35","author":"Gupta","year":"2020","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2026.05.006_bib0105","first-page":"EC10","article-title":"Adverse events associated with plateletpheresis: a tertiary care hospital experience in Southern India","volume":"13","author":"Shanthi","year":"2019","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.tracli.2026.05.006_bib0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.transci.2013.06.003","article-title":"Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India","volume":"49","author":"Patidar","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2026.05.006_bib0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12288-016-0681-z","article-title":"Adverse events during apheresis procedures: audit at a tertiary hospital","volume":"33","author":"Dogra","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tracli.2026.05.006_bib0120","unstructured":"Central Drugs Standards Control Organisation. Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics (Second Amendment) Rules, 2020. available at https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadGazette_NotificationsFiles\/GSR166Ecomponents.pdf (accessed on 10 June 2026)."},{"key":"10.1016\/j.tracli.2026.05.006_bib0125","unstructured":"AABB Donor Hemovigilance Working Group. Severity grading tool for donor adverse events: a user brochure. Bethesda, MD: AABB. 2017 [accessed 2025 May 26]."},{"key":"10.1016\/j.tracli.2026.05.006_bib0130","first-page":"EC22","article-title":"A retrospective analysis of apheresis donor deferral and adverse reactions at a tertiary care centre in India","volume":"10","author":"Arora","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.tracli.2026.05.006_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-3148.2002.00372.x","article-title":"National audit of citrate toxicity in plateletpheresis donors","volume":"12","author":"Makar","year":"2002","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2026.05.006_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bjhh.2014.03.008","article-title":"Risk factors associated with the occurrence of adverse events in plateletpheresis donation","volume":"36","author":"Barbosa","year":"2014","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.tracli.2026.05.006_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jca.21838","article-title":"A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM. TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima Accel","volume":"36","author":"Arcot","year":"2021","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2026.05.006_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ajts.AJTS_138_17","article-title":"Comparative assessment of single-donor plateletpheresis by Haemonetics\u00ae MCS\u00ae plus and Trima Accel\u00ae","volume":"14","author":"Baruah","year":"2020","journal-title":"Asian J Transfus Sci"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782026000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782026000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:42:55Z","timestamp":1788360175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782026000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1246782026000777"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2026.05.006","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 francophone de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}